Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liyun Yuan

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Molecular Aspects of Medicine|September 13, 2008
Glutathione in liver diseases and hepatotoxicityLiyun Yuan, Neil Kaplowitz
Clinics in Liver Disease|October 9, 2013
Mechanisms of drug-induced liver injuryLiyun Yuan, Neil Kaplowitz
World Journal of Hepatology|December 16, 2015
Bile acid receptors and nonalcoholic fatty liver diseaseLiyun Yuan, Kiran Bambha
Clinical Liver Disease|March 31, 2022
Nonalcoholic Fatty Liver Disease: The Role of Visceral Adipose TissueCourtney L Hanlon, Liyun Yuan
Current Hepatology Reports|June 12, 2020
NAFLD in women: Unique pathways, biomarkers and therapeutic opportunitiesLiyun Yuan, Ani Kardashian, Monika Sarkar
Pharmaceutical Research|March 24, 2005
Reversible lipidization prolongs the pharmacological effect, plasma duration, and liver retention of octreotideLiyun Yuan, Jeff Wang, Wei-Chiang Shen
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 2, 2008
Lipidization of human interferon-alpha: a new approach toward improving the delivery of protein drugsLiyun Yuan, Jeff Wang, Wei-Chiang Shen
Annual Review of Physiology|February 10, 2025
At the Crossroads of Health and Disease: Consequences of Fat in the LiverMatthew Dukewich, Liyun Yuan, Norah A Terrault
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 11, 2008
Reversible lipidization of somatostatin analogues for the liver targetingLiyun Yuan, Jeff Wang, Wei-Chiang Shen
BMJ Open Ophthalmology|September 24, 2024
Alterations in anterior lens capsule structure and LTBP-2 expression in primary angle-closure glaucomaXiaofeng Tian, Liyun Yuan, Liangpin Li, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Molecular Aspects of Medicine|September 13, 2008
Glutathione in liver diseases and hepatotoxicityLiyun Yuan, Neil Kaplowitz
Clinics in Liver Disease|October 9, 2013
Mechanisms of drug-induced liver injuryLiyun Yuan, Neil Kaplowitz
World Journal of Hepatology|December 16, 2015
Bile acid receptors and nonalcoholic fatty liver diseaseLiyun Yuan, Kiran Bambha
Clinical Liver Disease|March 31, 2022
Nonalcoholic Fatty Liver Disease: The Role of Visceral Adipose TissueCourtney L Hanlon, Liyun Yuan
Current Hepatology Reports|June 12, 2020
NAFLD in women: Unique pathways, biomarkers and therapeutic opportunitiesLiyun Yuan, Ani Kardashian, Monika Sarkar
Pharmaceutical Research|March 24, 2005
Reversible lipidization prolongs the pharmacological effect, plasma duration, and liver retention of octreotideLiyun Yuan, Jeff Wang, Wei-Chiang Shen
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 2, 2008
Lipidization of human interferon-alpha: a new approach toward improving the delivery of protein drugsLiyun Yuan, Jeff Wang, Wei-Chiang Shen
Annual Review of Physiology|February 10, 2025
At the Crossroads of Health and Disease: Consequences of Fat in the LiverMatthew Dukewich, Liyun Yuan, Norah A Terrault
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 11, 2008
Reversible lipidization of somatostatin analogues for the liver targetingLiyun Yuan, Jeff Wang, Wei-Chiang Shen
BMJ Open Ophthalmology|September 24, 2024
Alterations in anterior lens capsule structure and LTBP-2 expression in primary angle-closure glaucomaXiaofeng Tian, Liyun Yuan, Liangpin Li, et al.
Pageof 8